AzTrials
AzTrials

MyositisPIMANTNCT07552220

Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

An observational study of Myositis and Health Adult Subjects, run by Centre Hospitalier de Mâcon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Myositis, Health Adult Subjects
How many people
20 participants
Where
1 siteFrance
Study dates
Apr 2026to Dec 2028
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Myositis or healthy major patients

Who may be able to join

  • Patient > 18 years old ans has given his oral consent
  • Patient who biospies are performed as part of care

Who cannot join

  • Patient < 18 years old

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Thibault Maillet, Doctor contact

+333 85 27 73 43

thmaillet@ch-macon.fr

Emilie Chopin, Biology master contact

+333 85 27 56 86

emchopin@ch-macon.fr

France1 site
  • Centre Hospitalier de Mâcon

    Mâcon, 71000

Other trials in France

About this study

Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Anatomic pathology is the conventional method used to analyze muscle lesions, but it requires several weeks to obtain results. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer advantages in terms of speed and resolution for visualizing muscle inflammation.

This research project compares histological pathology and full-field OCT for the analysis of muscle biopsies from healthy individuals and patients suspected of having myositis. The aim of this study is to establish an OCT reference standard by analyzing control muscle biopsies and then comparing muscle inflammation in confirmed cases of myositis. The advantages and limitations of both methods will also be evaluated.

Read the detailed description

Introduction Myositis represents a group of inflammatory diseases affecting skeletal muscles, characterized by inflammatory infiltration of muscle tissue. This condition can have various etiologies, such as infections, autoimmune diseases (like dermatomyositis or polymyositis), or drug-induced diseases. Early diagnosis and accurate assessment of muscle inflammation are essential for the therapeutic management of these patients.

Conventional analytical techniques, such as histopathology, allow visualization and analysis of muscle lesions and inflammation using stains on histological sections. However, this method requires several weeks of work before a result can be obtained. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer significant advantages in terms of speed of examination and resolution of muscle structures, particularly for visualizing inflammatory infiltration.

This research project proposes to compare conventional histopathology and full-field optical coherence tomography for the analysis of muscle biopsies from both healthy individuals and patients with suspected myositis.

The main objective of this prospective and comparative study will be to first establish a reference standard by analyzing control biopsies using both methods, and then to similarly evaluate the muscle inflammation detected in confirmed cases of myositis. The respective advantages and limitations of each technique will be assessed in the detection of this pathology.

Research Objectives

  1. To analyze the spatial resolution of both methods for visualizing histopathological details at the level of muscle fibers, connective tissue, and blood vessels.
  2. To compare the ability of conventional histopathology and full-field optical coherence tomography (OCT) to detect muscle inflammation in muscle biopsies from healthy individuals and patients with myositis.
  3. To evaluate the diagnostic accuracy of both techniques in identifying inflammation-related abnormalities, such as inflammatory cell infiltration (lymphocytes, macrophages), muscle fiber degradation, and fibrosis.
  4. To compare the acquisition time and ease of use of each method for analyzing muscle tissue in a clinical setting.

Hypotheses Full-field optical coherence tomography will enable real-time visualization of inflammatory infiltration and muscle abnormalities with microscopic resolution, in a non-invasive, rapid, and dynamic manner.

These results could very quickly complement those obtained by anatomopathology which aims to describe the classic histopathological aspects of myositis, such as muscle necrosis, inflammatory infiltration, and fibrosis.

Methodology

  1. Sample Selection
  • Patient Groups:
  • Group 1 (healthy patients): Muscle biopsies from approximately ten healthy adult patients with no history of muscular, neurodegenerative, or inflammatory disease, undergoing orthopedic surgery. The age range should be variable (18-90 years) to be representative of the population and to account for natural age-related atrophy.
  • Group 2 (patients with suspected myositis): Muscle biopsies from adult patients presenting with clinical symptoms consistent with myositis (muscle fatigue, pain, muscle weakness) and clinical suspicion confirmed by other diagnostic tests (e.g., serology, EMG, clinical examination). Healthy muscle tissue will be obtained from a resection necessary during orthopedic surgery. This surgical waste does not constitute additional samples. Biopsies for suspected myositis will be performed as part of the diagnostic process and do not require any additional sampling. An information sheet will be given to the patient, and the surgeon will obtain their consent before the procedure. All patients must be of legal age, affiliated with or covered by the social security system, and not subject to any legal guardianship or protective measures. Pregnant women and adults unable to express their consent cannot be included in the research protocol.
  1. Conventional Anatomopathological Analysis
  • Samples will be frozen in ispoentane, stored at -80°C, and then transported on dry ice to the Anatomopathology Department of the Hospices Civils de Lyon for section labeling.
  • Histological staining of healthy tissues: Three standard stains will be performed on control biopsies (hematoxylin and eosin (H\&E), Gomori stain, fiber typing) to collect structural and metabolic data.
  • Histological staining in cases of suspected myositis: The three standard stains will also be performed, as well as stains for inflammatory markers, namely the major histocompatibility complex (HLA I, HLA DR), complement (C5b9), autophagy (p62), and clusters of differentiation (CD56, CD31).
  1. Full-field optical coherence tomography (OCT) analysis
  • Full-field OCT technology allows for micrometer-resolution imaging without the need for prior sample preparation. OCT will be used to image muscle tissue samples in real time, both structurally (FF-OCT) and dynamically (DCI). A series of 1 µm slices will be acquired. The images will then be converted by an algorithm to reproduce hematoxylin and eosin staining.
  • OCT images could allow visualization of muscle fiber structure, surrounding connective tissue, and areas of inflammatory infiltration.
  1. Comparison of methods Qualitative analysis: The images obtained by OCT will be visually compared to images obtained by conventional histology after scanning the slides. This comparison will be conducted by specialized anatomical pathologists to evaluate the ability of each method to detect muscle abnormalities and inflammation. An artificial intelligence algorithm may be used to facilitate the comparison.
  2. Expected Results The results will allow us to evaluate the clinical value of OCT as an alternative or complementary imaging method to conventional histopathology. If OCT proves effective for detecting muscle inflammation, it could become a valuable tool for ultra-rapid diagnosis.
Keywords
anatomopathology, Full field optical coherence tomography, muscle biopsies, Myositis and healthy patients
Medical subject headings
Myositis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07552220
Study groupRoleWhat they receive
Healthy patientsMuscle biopsies collected during orthopedic surgery (performed as part of care)
Myositis patientsMuscle biopsies collected as part of care to establish a diagnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the spatial resolution of the two methods

    Image acquisitions will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness.

    To obtain structural tissue data, OCT acquisitions will be performed in full field mode (FF-OCT), and Hematoxylin-Eosin, Gomori's trichrome and NADH staining will be carried out on histological sections.

    For each method, the criteria evaluated will be the ability to detect fiber structure, the presence of fibrosis and blood vessels.

    Image comparison will be performed by specialized pathologists and then by an autoML type artificial intelligence, with assessment of accuracy and recall.

    Measured: 2 years

  2. Evaluation of inflammation detection of the two methods

    Image acquisition will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness.

    OCT acquisitions will be carried out in dynamic colorimetric mode (DCI) to observe the intensity and variability of metabolic activity across the entire fresh tissue sample using a color panel ranging from blue to red.

    Inflammation detection on histological sections will be observed using the markers HLA1, HLA-DR, C5B9, P62, CD31, CD56. The potential correlation between metabolic activity and inflammation will be visually assessed by specialized pathologists and by an autoML type artificial intelligence with assessment of accuracy and recall.

    Measured: 2 years

Secondary outcomes (1)
  1. Establish the advantages and limitations of the two methods

    Define the averages for sample preparation time, acquisition time and result delivery time for each method.

    Compare the quality of the results obtained by the two techniques according to the two previous evaluation criteria (visual assessment by pathologists, accuracy, recall and AI F1 score)

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionApr 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07552220
Sponsor's protocol ID
PIMANT
Acronym
PIMANT
Status last verified
Apr 2026
First submitted
3 Apr 2026
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Myositis and Health Adult Subjects, run by Centre Hospitalier de Mâcon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thibault Maillet, Doctor (+333 85 27 73 43, thmaillet@ch-macon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the spatial resolution of the two methods (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in